SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-07-016383
Filing Date
2007-08-14
Accepted
2007-08-14 16:27:49
Documents
1
Period of Report
2006-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 3620
  Complete submission text file 0001140361-07-016383.txt   5849
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1101 BRICKELL AVE #701 S MIAMI FL 33131
Business Address C/O DISCOVERY LABORATORIES INC 3359 DURHAM ROAD DOYLESTOWN PA 18901 305-534-3383
SCHABER CHRISTOPHER J (Reporting) CIK: 0001068029 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-16929 | Film No.: 071055641